10x Science Raises $4.8 Million in Seed Funding
Charlottesville-based 10x Science has successfully raised $4.8 million in a seed funding round. The round was led by Initialized Capital, with participation from Founder Factor, Civilization Ventures, and Y Combinator. The company specializes in advanced peptide mapping technology designed to enhance protein therapeutics by offering processing speeds that are ten times faster than current tools, eliminating file conversions, and reducing friction in workflows.
Leadership Team
10x Science was founded by a team of experts including David Roberts, who serves as the CEO, Vishnu Tejus as the CTO, and Andrew Reiter as the COO. Together, they bring a wealth of experience and expertise to the company. Roberts has been instrumental in steering the company's vision towards transforming the field of protein therapeutics.
Investment and Future Plans
The funds raised in this seed round are expected to be used to further develop the company's innovative technology and expand its market reach. While specific plans for the use of the funds were not disclosed, investments of this nature typically support product development, scaling operations, and enhancing customer acquisition efforts.
Key Investors
Initialized Capital led the investment round, marking another significant entry into the biotech space for the venture capital firm. Other participants included Founder Factor, Civilization Ventures, and Y Combinator, each bringing valuable experience and resources to support 10x Science's growth.
Conclusion
The successful completion of this funding round positions 10x Science to accelerate its development efforts and capitalize on its unique technology for peptide mapping. With the backing of prominent investors, the company is set to make significant strides in improving the efficiency and accuracy of protein therapeutics.